Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Markedly increased diamine oxidase during acute anaphylaxis is associated with an underlying clonal mast cell disorder
Authors:ID Rijavec, Matija, Univerzitetna klinika za pljučne bolezni in alergijo Golnik (Author)
ID Kogovšek, Žan, Univerzitetna klinika za pljučne bolezni in alergijo Golnik (Author)
ID Inkret, Jezerka (Author)
ID Kopač, Peter, Univerzitetna klinika za pljučne bolezni in alergijo Golnik (Author)
ID Korošec, Peter, Univerzitetna klinika za pljučne bolezni in alergijo Golnik (Author)
Files:URL URL - Source URL, visit https://onlinelibrary.wiley.com/doi/full/10.1111/cea.70227
 
.pdf PDF - Presentation file, download (698,24 KB)
MD5: 99285E4DAF2B19C3403BF386F9D3ED20
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo UKPBAG - University Clinic of Respiratory and Allergic Diseases Golnik
Abstract:Introduction Diamine oxidase (DAO) degrades histamine, the key mediator in anaphylaxis, yet its relationship with clonal mast cell disorder (CMD) in the context of anaphylaxis is unclear. We evaluated whether DAO during anaphylaxis differs by CMD status. Methods We enrolled 35 emergency-department patients with acute anaphylaxis to drugs (7 patients), food (2 patients), or Hymenoptera venom (26 patients). Tryptase, DAO, and histamine degradation were measured during anaphylaxis and convalescence. CMD was defined by detecting KIT p.D816V in peripheral blood leukocytes using highly sensitive qPCR. Post-mortem DAO and tryptase were also compared in two fatal Hymenoptera venom-triggered anaphylaxis (HVA) cases with CMD versus 13 non-anaphylaxis controls. Results KIT p.D816V was detected in 6 (17%); all had severe HVA and normal basal tryptase. During anaphylaxis, DAO increased markedly in CMD (median 1142%), but only modestly in KIT p.D816V-negative patients (median 20%; p < 0.0001), independent of trigger or severity. Acute DAO was ~5-fold higher in CMD (median 101 vs. 18 U/mL), while convalescent DAO was similar (both 14 U/mL). Despite markedly elevated DAO, we observed impaired histamine degradation in acute anaphylaxis plasma. Receiver-operating-characteristic analyses showed strong discrimination for CMD using acute DAO (AUC 0.92; cut-off 53 U/mL; sensitivity 83%; specificity 97%) and percentage increase from convalescence (AUC 0.97; cut-off 223%; sensitivity 83%; specificity 100%). Post-mortem DAO lacked specificity, whereas post-mortem tryptase supported the diagnosis of fatal anaphylaxis and CMD. Conclusion DAO concentrations rise markedly during anaphylaxis in CMD and may help identify individuals at the highest risk. Further studies should refine the diagnostic utility and elucidate the mechanisms by which DAO may amplify anaphylaxis in CMD.
Keywords:anaphylaxis, clonal mast cell disorder, diamine oxidase, KIT p.D816V, tryptase
Publication status:Published
Publication version:Version of Record
Submitted for review:30.10.2025
Article acceptance date:23.01.2026
Publication date:29.01.2026
Publisher:Blackwell Science, 1997-
Year of publishing:2026
Number of pages:str. 516-525
Numbering:Vol. 56, issue 5
Source:Clinical & experimental allergy
PID:20.500.12556/DiRROS-29284 New window
UDC:616-008.61
ISSN on article:1365-2222
DOI:10.1111/cea.70227 New window
COBISS.SI-ID:266808579 New window
Copyright:"© 2026 The Author(s). Clinical & Experimental Allergy published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited."
Note:Nasl. z nasl. zaslona; Opis vira z dne 5. 5. 2026;
Publication date in DiRROS:06.05.2026
Views:34
Downloads:23
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Clinical & experimental allergy
Shortened title:Clin. exp. allergy
Publisher:Blackwell Science
ISSN:1365-2222
COBISS.SI-ID:515014681 New window

Document is financed by a project

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P3-0360
Name:Celostna obravnava alergijskih bolezni in astme v Sloveniji: od epidemiologije do genetike

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J3-50114
Name:S preučevanjem celotnega genoma do razumevanja genetskega ozadja anafilaksije

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:29.01.2026
Applies to:Version of Record valid from 2026-01-29

Secondary language

Language:Slovenian
Keywords:anafilaksija, klonalna motnja mastocitov, diamin oksidaza, DAO, KIT p.D816V, triptaza


Back